P&G Intrinsa Could Inaugurate Female Sexual Dysfunction Market In 2005
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Procter & Gamble’s Intrinsa could be the first treatment for female sexual dysfunction to reach the market, with potential approval as early as 2005.